Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
[Changing Clinical Presentation of Acute Coronary Syndrome in Patients With Chronic Obstructive Pulmonary Disease]
V K Zafiraki1, A M Namitokov1, E D Kosmacheva1
11Kuban State Medical University, Krasnodar, Russia; 2Scientific Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; 3Central Hospital of Oilworkers, Baku, Azerbaijan; 4Educational Scientific Medical Centre of the General Management Department of the President of RF, Russia.
Objective:
to determine clinical features of acute coronary syndrome (ACS) in patients with chronic obstructive pulmonary disease (COPD).
Methods:
We included into this study 272 patients with ACS, 110 with and 162 without concomitant COPD. In both groups we registered prevalence of atypical forms of ACS debut, severity of acute heart failure (Killip class), time from symptoms onset prior to percutaneous coronary intervention (PCI), as well as the prevalence of cardiac arrhythmias.
Results:
Demographic characteristics and presence.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease III: Clinical Manifestations

